No Data
No Data
Express News | Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Press Release: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Earnings Preview: AKBA to Report Financial Results Pre-market on November 07
Akebia Therapeutics to Report Third Quarter 2024 Financial Results and Discuss Recent Business Highlights
Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Shares Bounce 29% But Its Business Still Trails The Industry
Market Sentiment Around Loss-Making Akebia Therapeutics, Inc. (NASDAQ:AKBA)
No Data
No Data